GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
2 518,90 ₹
arrow_upward
+0,84%(+20,90) 1D
29 հոկ, 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
2 498,00 ₹
High
2 540,00 ₹
Low
2 495,00 ₹
Mkt. cap
425,76 մլրդ
Avg. vol.
64,33 հզր
Volume
41,28 հզր
Dividend
2,26%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,95
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
Open
2 498,00 ₹
High
2 540,00 ₹
Low
2 495,00 ₹
Mkt. cap
425,76 մլրդ
Avg. vol.
64,33 հզր
Volume
41,28 հզր
Dividend
2,26%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,95
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
FinancialContent
·
1 ժամ առաջ
Carrier Global’s (NYSE:CARR) Q3 2026 sales top estimates, guides for strong full-year sales
Yahoo Finance
·
20 րոպե առաջ
Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Reuters
·
1 ժամ առաջ
Nasdaq futures fall 1% as Alphabet results intensify AI spending fears
Bloomberg.com
·
5 ժամ առաջ
Tech Rally Stalls as Alphabet, Samsung Disappoint: Markets Wrap
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd